Alzheon

Alzheon

Alzheon

Alzheon, Inc., is a clinical-stage biotechnology company focused on brain health, memory and aging, developing a pipeline of innovative.
Founded
2013
Raised
$13.1M
Follow us
Alexa global traffic share
Latest funding
$10,000,000
Venture capital (Series A) - 2015
$3,050,000
Venture capital - 2015
Team Size
1–10
Employees
Xconomy

Alzheon Files for IPO to Fund Studies of Amyloid Alzheimer’s Drug

Health